Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Nanoparticle orientation offers a way to enhance drug delivery: Coating particles with 'right-handed' molecules could help them penetrate cancer cells more easily

MIT engineers created clusters of nanoparticles that are coated with "right-handed" molecules of the amino acid cysteine.

CREDIT
Jihyeon Yeom
MIT engineers created clusters of nanoparticles that are coated with "right-handed" molecules of the amino acid cysteine. CREDIT Jihyeon Yeom

Abstract:
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling a trait of chemical structures known as chirality -- the "handedness" of the structure.

Nanoparticle orientation offers a way to enhance drug delivery: Coating particles with 'right-handed' molecules could help them penetrate cancer cells more easily

Cambridge, MA | Posted on November 5th, 2019

Many biological molecules can come in either right-handed or left-handed forms, which are identical in composition but are mirror images of each other.

The MIT team found that coating nanoparticles with the right-handed form of the amino acid cysteine helped the particles to avoid being destroyed by enzymes in the body. It also helped them to enter cells more efficiently. This finding could help researchers to design more effective carriers for drugs to treat cancer and other diseases, says Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute for Integrative Cancer Research.

"We are very excited about this paper because controlling chirality offers new possibilities for drug delivery and hence new medical treatments," says Langer, who is one of the senior authors of the paper.

Ana Jaklenec, a research scientist at the Koch Institute, is also a senior author of the paper, which appears in Advanced Materials on Nov. 4. The paper's lead author is MIT postdoc Jihyeon Yeom. Other authors of the paper are former MIT postdocs Pedro Guimaraes and Kevin McHugh, MIT postdoc Quanyin Hu, and Koch Institute research affiliate Michael Mitchell. Hyo Min Ahn, BoKyeong Jung, and Chae-Ok Yun of Hanyang University in Seoul, South Korea, are also authors of the paper.

Chiral interactions

Many biologically important molecules have evolved to exist exclusively in either right-handed ("D") or left-handed ("L") versions, also called enantiomers. For example, naturally occurring amino acids are always "L" enantiomers, while DNA and glucose are usually "D."

"Chirality is ubiquitous in nature, imparting uniqueness and specificity to the biological and chemical properties of materials," Yeom says. "For example, molecules formed with the same composition taste sweet or bitter and smell differently depending on their chirality, and one enantiomer is inactive or even toxic while the other enantiomer can serve an important biological function."

The MIT team hypothesized that it might be possible to take advantage of chiral interactions to improve the performance of drug-delivery nanoparticles. To test that idea, they created "supraparticles" consisting of clusters of 2-nanometer cobalt oxide particles whose chirality was provided by either the "D" or "L" version of cysteine on the surfaces.

By flowing these particles along a channel lined with cancer cells, including myeloma and breast cancer cells, the researchers could test how well each type of particle was absorbed by the cells. They found that particles coated with "D" cysteine were absorbed more efficiently, which they believe is because they are able to interact more strongly with cholesterol and other lipids found in the cell membrane, which also have the "D" orientation.

The researchers also believed that the "D" version of cysteine might help nanoparticles avoid being broken down by enzymes in the body, which are made of "L" amino acids. This could allow the particles to circulate in the body for longer periods of time, making it easier for them to reach their intended destinations.

In a study of mice, the researchers found that "D"-coated particles did stay in the bloodstream longer, suggesting that they were able to successfully evade enzymes that destroyed the "L"-coated particles. About two hours after injection, the number of "D" particles in circulation was much greater than the number of "L" particles, and it remained higher over the 24 hours of the experiment.

"This is a first step in looking at how chirality can potentially aid these particles in reaching cancer cells and increasing circulation time. The next step is to see if we could actually make a difference in cancer treatment," Jaklenec says.

Modified particles

The researchers now plan to test this approach with other types of drug-delivery particles. In one project, they are investigating whether coating gold particles with "D" amino acids will improve their ability to deliver cancer drugs in mice. In another, they are using this approach to modify adenoviruses, which some of their collaborators are developing as a potential new way to treat cancer.

"In this study, we showed that the 'D' chirality allows for longer circulation time and increased uptake by cancer cells. The next step would be to determine if drug-loaded chiral particles give enhanced or prolonged efficacy compared to free drug," Jaklenec says. "This is potentially translatable to essentially any nanoparticle."

###

The research was funded by the Koch Institute's Marble Center for Cancer Nanomedicine, the National Council for Scientific and Technological Development of Brazil, the Estudar Foundation, a Ruth L. Kirschstein National Research Service Award, a Burroughs Wellcome Fund Career Award at the Scientific Interface, an National Institutes of Health Director's New Innovator Award, the American Cancer Society, an AACR-Bayer Innovation and Discovery Grant, and the National Research Foundation of Korea.

####

For more information, please click here

Contacts:
Sarah McDonnell

617-253-8923

@MIT

Copyright © Massachusetts Institute of Technology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

RELATED JOURNAL ARTICLE:

Related News Press

News and information

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Year End Results November 11th, 2019

Scientists probe the limits of ice: Transition between ice and liquid water gets fuzzy at the nanoscale November 9th, 2019

Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019 November 8th, 2019

Cancer

New drug-delivery technology promises efficient, targeted cancer treatment October 22nd, 2019

Novel nanogels hold promise for improved drug delivery to cancer patients: 'Precision Medicine' approach underpins UT Austin engineers' development of multifunctional nanogel September 27th, 2019

SMART announces a revolutionary tech to study cell nanomechanics: New research discovery enables scientists to study membrane mechanics of cell's nucleus, revolutionising the understanding of metastatic cancers as well as opening the doors for identification of stem cells for the September 20th, 2019

Tiny bubbles in our body could fight cancer better than chemo September 18th, 2019

Govt.-Legislation/Regulation/Funding/Policy

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Scientists probe the limits of ice: Transition between ice and liquid water gets fuzzy at the nanoscale November 9th, 2019

Argonne collaborates to review current battery recycling processes for electric vehicles November 8th, 2019

Go with the flow: Scientists design new grid batteries for renewable energy: New blueprint for affordable, sustainable 'flow batteries' developed at Berkeley Lab could accelerate an electrical grid powered by the sun and wind November 8th, 2019

Possible Futures

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Year End Results November 11th, 2019

Scientists probe the limits of ice: Transition between ice and liquid water gets fuzzy at the nanoscale November 9th, 2019

Self-assembled microspheres of silica to cool surfaces without energy consumption November 8th, 2019

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Year End Results November 11th, 2019

Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019 November 8th, 2019

Picosun expands selection of biocompatible ALD materials for medical applications November 4th, 2019

Disordered proteins become stable, 'super-sticky' materials: Improved protein control could lead to wound-healing gels and other applications November 3rd, 2019

Discoveries

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Scientists probe the limits of ice: Transition between ice and liquid water gets fuzzy at the nanoscale November 9th, 2019

Thorium superconductivity: Scientists discover a new high-temperature superconductor November 8th, 2019

Self-assembled microspheres of silica to cool surfaces without energy consumption November 8th, 2019

Announcements

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Year End Results November 11th, 2019

Scientists probe the limits of ice: Transition between ice and liquid water gets fuzzy at the nanoscale November 9th, 2019

A distinct spin on atomic transport: Work that demonstrates simultaneous control over transport and spin properties of cold atoms establishes a framework for exploring concepts of spintronics and solid-state physics November 8th, 2019

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Scientists probe the limits of ice: Transition between ice and liquid water gets fuzzy at the nanoscale November 9th, 2019

Self-assembled microspheres of silica to cool surfaces without energy consumption November 8th, 2019

Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019 November 8th, 2019

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

New technique lets researchers map strain in next-gen solar cells November 1st, 2019

Promising discovery could lead to a better, cheaper solar cell: Scientific instrument made at McGill reveals liquid-like properties of a solid substance November 1st, 2019

Quantum supremacy milestone harnesses ORNL Summit supercomputer October 25th, 2019

Nanobiotechnology

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Year End Results November 11th, 2019

Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019 November 8th, 2019

Disordered proteins become stable, 'super-sticky' materials: Improved protein control could lead to wound-healing gels and other applications November 3rd, 2019

Research partnerships

Moving diagnostics out of the lab and into your hand: Electrochemical sensor platform technology could enable portable, multiplexed, point-of-care diagnostics for a wide range of applications November 11th, 2019

Cage molecules act as molecular sieves for hydrogen isotope separation November 1st, 2019

New technique lets researchers map strain in next-gen solar cells November 1st, 2019

Small magnets reveal big secrets: Work by international research team could have wide-ranging impact on information technology applications October 28th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project